Key Lab of Vaccine against Hemorrhagic Fever with Renal Syndrome, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Centre of Laboratory Medicine, Zhejiang Provincial People's Hospital.
Int J Biol Sci. 2017 Nov 1;13(11):1387-1397. doi: 10.7150/ijbs.21635. eCollection 2017.
Breast cancer is the second leading cause of cancer deaths among women. The development of breast cancer is a multi-step process involving multiple cell types, and its prevention remains challenging in the world. Early diagnosis of breast cancer is one of the best approaches to prevent this disease. In some developed countries, the 5-year relative survival rate of breast cancer patients is above 80% due to early prevention. In the recent decade, great progress has been made in the understanding of breast cancer as well as in the development of preventative methods. The pathogenesis and tumor drug-resistant mechanisms are revealed by discovering breast cancer stem cells, and many genes are found related to breast cancer. Currently, people have more drug options for the chemoprevention of breast cancer, while biological prevention has been recently developed to improve patients' quality of life. In this review, we will summarize key studies of pathogenesis, related genes, risk factors and preventative methods on breast cancer over the past years. These findings represent a small step in the long fight against breast cancer.
乳腺癌是女性癌症死亡的第二大主要原因。乳腺癌的发生是一个多步骤的过程,涉及多种细胞类型,其预防在世界范围内仍然具有挑战性。早期诊断乳腺癌是预防这种疾病的最佳方法之一。在一些发达国家,由于早期预防,乳腺癌患者的 5 年相对生存率超过 80%。在最近十年中,人们对乳腺癌的发病机制和肿瘤耐药机制的认识以及预防方法的发展取得了巨大进展。通过发现乳腺癌干细胞,揭示了乳腺癌的发病机制和肿瘤耐药机制,并且发现了许多与乳腺癌相关的基因。目前,人们有更多的药物选择用于乳腺癌的化学预防,而生物预防最近也得到了发展,以提高患者的生活质量。在这篇综述中,我们将总结过去几年中关于乳腺癌发病机制、相关基因、危险因素和预防方法的关键研究。这些发现代表着在与乳腺癌长期斗争中的一小步。